IRIS
OREFICE, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 3.256
NA - Nord America 2.903
EU - Europa 2.264
SA - Sud America 377
AF - Africa 92
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 8.899
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.752
SG - Singapore 1.421
RU - Federazione Russa 1.056
VN - Vietnam 662
CN - Cina 588
IT - Italia 389
BR - Brasile 299
HK - Hong Kong 280
DE - Germania 168
FI - Finlandia 125
NL - Olanda 125
FR - Francia 108
CA - Canada 93
IE - Irlanda 64
GB - Regno Unito 63
IN - India 60
JP - Giappone 51
UA - Ucraina 43
MX - Messico 39
AR - Argentina 37
ZA - Sudafrica 31
SE - Svezia 27
IQ - Iraq 25
BD - Bangladesh 23
CI - Costa d'Avorio 23
PH - Filippine 19
PL - Polonia 18
TH - Thailandia 18
AT - Austria 16
ES - Italia 16
KR - Corea 15
TR - Turchia 14
LT - Lituania 13
ID - Indonesia 10
PY - Paraguay 10
TW - Taiwan 10
AE - Emirati Arabi Uniti 9
EG - Egitto 9
BE - Belgio 8
DK - Danimarca 8
EC - Ecuador 8
PK - Pakistan 8
KE - Kenya 7
MA - Marocco 7
VE - Venezuela 6
CL - Cile 5
CO - Colombia 5
IR - Iran 5
LB - Libano 4
SA - Arabia Saudita 4
AL - Albania 3
GE - Georgia 3
JO - Giordania 3
KZ - Kazakistan 3
LY - Libia 3
MK - Macedonia 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
XK - ???statistics.table.value.countryCode.XK??? 3
AZ - Azerbaigian 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HT - Haiti 2
KG - Kirghizistan 2
KH - Cambogia 2
MR - Mauritania 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PE - Perù 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AI - Anguilla 1
AM - Armenia 1
BF - Burkina Faso 1
BJ - Benin 1
BZ - Belize 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EU - Europa 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KW - Kuwait 1
LC - Santa Lucia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 8.888
Salva come PNG Salva come JPEG
Città #
Singapore 622
San Jose 535
Hong Kong 262
Moscow 237
Ashburn 225
Chandler 202
Beijing 201
Ho Chi Minh City 198
Hanoi 135
Amsterdam 115
Santa Clara 112
Los Angeles 102
Naples 100
Munich 80
Princeton 80
Millbury 75
The Dalles 70
Lauterbourg 67
Nanjing 57
Tokyo 51
Dallas 47
Boston 46
New York 43
Ottawa 43
Da Nang 35
Buffalo 33
Jacksonville 33
Wilmington 32
Napoli 29
São Paulo 27
Des Moines 26
Orem 25
Seattle 24
Turku 24
Haiphong 23
Helsinki 23
Norwalk 23
Redondo Beach 23
Hefei 22
Chennai 21
Denver 20
Mexico City 19
Houston 18
Toronto 18
Tianjin 17
Nanchang 16
Rome 16
Warsaw 16
Milan 15
Atlanta 14
Brooklyn 13
Columbus 13
Hebei 13
Johannesburg 13
Montreal 13
Stockholm 13
Chicago 12
Dong Ket 12
Jiaxing 12
Mumbai 12
Poplar 12
London 11
Phoenix 11
Rio de Janeiro 11
Augusta 10
Baghdad 10
Shenyang 10
Brasília 9
Council Bluffs 9
Thái Bình 9
Brussels 8
Curitiba 8
Falkenstein 8
Frankfurt am Main 8
Thái Nguyên 8
Ankara 7
Biên Hòa 7
Can Tho 7
Nairobi 7
Palermo 7
Washington 7
Bangkok 6
Bari 6
Boardman 6
Erbil 6
Guangzhou 6
Hải Dương 6
Manchester 6
Miami 6
Phủ Lý 6
Pune 6
Querétaro 6
San Francisco 6
Asunción 5
Bắc Giang 5
Calgary 5
Catania 5
Düsseldorf 5
Florence 5
Fortaleza 5
Totale 4.714
Salva come PNG Salva come JPEG
Nome #
Nuove tecniche di imaging nello studio delle alterazioni perfusionali cerebrali e dei processi di degenerazione neuronale in soggetti affetti da sclerosi multipla e da altre patologie neurologiche degenerative. Associazioni tra marcatori radiologici e polimorfismi genetici di predisposizione e decorso delle malattie neurodegenerative 241
Immunometabolic profiling of T cells from patients with relapsing-remitting multiple sclerosis reveals an impairment in glycolysis and mitochondrial respiration 172
Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. 166
Assessment of neuroactive steroids in cerebrospinal fluid comparing acute relapse and stable disease in relapsing-remitting multiple sclerosis 164
The effects of mechanical focal vibration on walking impairment in multiple sclerosis patients: A randomized, double-blinded vs placebo study 158
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 154
The Heterogeneity of Early Parkinson?s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients 153
Epileptic seizures in multiple sclerosis: clinical and EEG correlations. 150
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 150
Levetiracetam for cerebellar tremor in multiple sclerosis: an open-label pilot tolerability and efficacy study. 149
Inhibition of oligodendrocyte differentiation by immunoglobulin purified from serum of multiple sclerosis patients during relapse 148
Multiple sclerosis and headache co-morbidity. A case-control study 146
Upper motor neuron evaluation in multiple sclerosis patients treated with Sativex(®) 144
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. NeuroImage18: 360-366, 2003.. 143
Grey matter loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study. 141
The IFN-β 1b effect on Cu Zn superoxide dismutase (SOD1) in peripheral mononuclear blood cells of relapsing-remitting multiple sclerosis patients and in neuroblastoma SK-N-BE cells 141
Pragmatic abilities in multiple sclerosis: The contribution of the temporo-parietal junction 137
Vitamin D in a population of Southern Italy relapsing remitting and secondary progressive multiple sclerosis patients. 133
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 130
Neuropsychological assessment, quantitative MRI and ApoE gene polymorphisms in a series of MS patients treated with IFN beta-1b. 128
Brain atrophy and lesion load in a large population of patients with multiple sclerosis 126
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing–Remitting Multiple Sclerosis 126
Long-term clinical experience with weekly interferon beta-1a in relapsing multiple sclerosis 125
Successful treatment of paraneoplastic cerebellar degeneration with Rituximab. 124
Communication in Multiple Sclerosis: Pragmatic Deficit and its Relation with Cognition and Social Cognition 122
Correlation between fatigue and brain atrophy and lesion load in multiple sclerosis patients independent of disability. 121
Analisi conoscitiva del grado di aderenza di strutture di riabilitazione alle principali linee guida nazionali nel trattamento di pazienti afasici e disfagici. 121
Predictive factors of neutralizing antibodies development in relapsing-remitting multiple sclerosis patients on interferon Beta-1b therapy. 120
Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. 119
Age-related risk factors for ischemic stroke in Italian men. 118
An open label randomised clinical trial of atorvastatin in combination with IFN beta-1a in active MS patients: 12 months results. 117
Three primitive reflexes in HIV-1-infected individuals: a possible clinical marker of early central nervous system involvement. 116
Natalizumab is effective in multiple sclerosis patients switching from other disease modifying therapies in clinical practice. 116
Aerodynamic findings and Voice Handicap Index in Parkinson’s disease 116
Brain atrophy in Relapsing-remitting multiple sclerosis patients treated with interferon-beta and atorvastatin (The ARIANNA study). 115
Recurrent pulmonary and cerebral thromboembolism in an adult patients following incomplete removal of ventriculoatrial shunt for congenital hydrocephalus. 113
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 113
Anatomical and functional retinal changes in multiple sclerosis 112
Prognostic value of combined target-organ damage in patients with essential hypertension 112
Gender differences in non-motor symptoms in early, drug naive Parkinson's disease 111
A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis 109
Absence of cerebrospinal fluid oligoclonal bands is associated with delayed disability progression in relapsing-remitting MS patients treated with interferon-beta. 108
Switching disease-modifying therapies in multiple sclerosis: follow-up of 108 patients. In MULTIPLE SCLEROSIS (Vol. 11, pp. S159-S159). 338 EUSTON ROAD, LONDON NW1 3BH, ENGLAND: HODDER ARNOLD, HODDER HEADLINE PLC. 107
Regional GM loss in MS: a comparison between Primary-Progressive and Relapsing-Remitting MS phenotypes. 105
Comparative effects of mesoglycan and ticlopidine treatment on some coagulative parameters in patients with previous ischemic stroke: Results of a randomized controlled trial 105
HLA-DRB1*1501 and response to copolymer-1 therapy in relapsing-remitting multiple sclerosis. 104
Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study 103
Transient global amnesia in a young woman on prolonged treatment with oral contraceptive drugs. 103
Benign intracranial hypertension of obese women. A twenty cases report. 103
The management of multiple sclerosis by reference centers in south of Italy: a 2011 survey on health demands and needs in Campania region 103
Serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in relapsing and secondary progressive IFN beta treated MS patients 102
Serum levels of insulin like growth factor-1 and insulin like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis 100
Clinical and computerized tomographic study of a case of Schilder's disease. 99
Do gonadotropins play a role in catamenial epilepsy? | [Le gonadotropine ipofisarie hanno un ruolo nella patogenesi delle crisi catameniali?]. 99
The results of two multicenter, open-label studies assessing efficacy, tolerability and safety of protiramer, a high molecular weight synthetic copolymeric mixture, in patients with relapsing-remitting multiple sclerosis. 98
Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension 98
Interferon beta-1a and atorvastatin combination therapy: 12-month results from an open-label, randomized, clinical study. 97
Differential effects of three interferon betas on neutralising antibodies in patients with multiple sclerosis: a follow up study in an independent laboratory. 92
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 90
No effect of acetylsalicylic acid on B-thromboglobulin and platelet factor 4 plasma levels in patients with transient ischaemic attacks. 90
B-thromboglobulin and Platelet Factor-4 Measured By A Radioimmunoassay As Indexes of Platelet Activation In Patients With Migraine 89
Correlation of disease severity and regional brain tissue loss in relapsing-remitting multiple sclerosis: a voxel-based morphometry study in a large population 89
Safety and tolerability in relapsing-remitting multiple sclerosis patients treated with high-dose subcutaneous interferon-beta by Rebiject autoinject on over a 1-year period: the CoSa study. 81
Antithrombotic effect of indobufen in an experimental model of arterio-arterial microanastomosis in the rat. 80
Dati aerodinamici della voce dei soggetti con malattia di Parkinson preliminari al trattamento riabilitativo logopedico 79
No effect of cloricromen on some coagulation parameters in patients with ischaemic cerebrovascular disease. 78
Is brain atrophy progression in RR-MS slowed by the association off atorvastatin and interferon beta-1a? Preliminary results from an open-label, randomized, clinical study 76
Interferon-beta treatment decreases cholesterol plasma levels in multiple sclerosis patients. 75
[The physiopathology of supranuclear structures in oculomotor disorders]. 75
Presence of papova-like viral particles in cerebrospinal fluid of AIDS patients with progressive multifocal leukoencephalopathy. An additional test for "in vivo" diagnosis. 75
Brain tissue volume changes in relapsing-remitting multiple sclerosis: correlation with lesion load. 72
Usefulness of the Radioimmunoassay of B-thromboglobulin In Transient Ischemic Attacks 71
No evidence for an effect on brain atrophy rate of atorvastatin add-on to interferon β1b therapy in relapsing-remitting multiple sclerosis (the ARIANNA study) 70
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. 69
Platelet-function In Childhood Migraine 68
[Fahr syndrome with and without hypoparathyroidism. 2 cases]. 68
Spontaneous resolution of Chiari type 1 malformation. A case report and literature review 68
Epilepsy and multiple sclerosis: Review of literature and our epilepsy center's experience 64
Post-exercise facilitation and depression of motor evoked potentials to transcranial magnetic stimulation: a study in multiple sclerosis 62
NAbs effect on cognitive, clinical and quantitative MRI outcome measures in RR-MS IFN beta-1b treated patients 60
Idiopathic intracranial hypertension in a patient with thyroid papillary carcinoma 57
Natalizumab vs interferon beta 1a inrelapsing-remitting multiple sclerosis: a head-to-head retrospective study. 51
Subcutaneous interferon ?-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study. 42
Totale 9.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202163 0 0 0 0 0 0 0 0 0 1 46 16
2021/2022411 5 0 0 2 1 18 1 16 67 48 86 167
2022/2023534 83 36 17 25 70 44 0 39 73 104 26 17
2023/2024504 15 69 134 38 34 45 10 44 5 7 77 26
2024/20252.328 120 87 8 33 74 120 241 153 158 274 848 212
2025/20264.420 496 235 411 516 876 140 730 191 513 312 0 0
Totale 9.045